PDL BioPharma, Inc. Capex per Share

Capex per Share of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex per Share growth rates and interactive chart. Capex per share refers to the total amount of capital expenditures paid in a period divided by the weighted average number of shares outstanding. If a company has capex of $100 million and 10 million shares outstanding, capex per share is $10.


Highlights and Quick Summary

  • Capex per Share for the quarter ending June 29, 2020 was -0.0 (a 50.0% increase compared to previous quarter)
  • Year-over-year quarterly Capex per Share decreased by -100.22%
  • Annual Capex per Share for 2019 was 0.69 (a 87.95% increase from previous year)
  • Annual Capex per Share for 2018 was 0.37 (a -46.19% decrease from previous year)
  • Annual Capex per Share for 2017 was 0.68 (a 755.58% increase from previous year)
  • Twelve month Capex per Share ending June 29, 2020 was 0.71 (a -10784.85% decrease compared to previous quarter)
  • Twelve month trailing Capex per Share decreased by -1.85% year-over-year
Trailing Capex per Share for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
0.71 -0.01 0.87 0.72
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex per Share of PDL BioPharma, Inc.

Most recent Capex per Shareof PDLI including historical data for past 10 years.

Interactive Chart of Capex per Share of PDL BioPharma, Inc.

PDL BioPharma, Inc. Capex per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -0.0 -0.0
2019 0.17 0.56 -0.02 -0.0 0.69
2018 0.14 -0.01 0.24 -0.01 0.37
2017 0.21 0.17 0.17 0.13 0.68
2016 0.15 -0.27 0.09 0.11 0.08
2015 0.21 -0.66 0.01 0.01 -0.44
2014 -0.28 0.2 0.06 0.16 0.13
2013 -1.73 0.0 0.0 0.0 -1.73
2012 0.0 0.0 0.0 0.0 -0.0
2011 0.0 0.0 -0.0 0.0 0.0
2010 0.0 0.0 0.0 0.0

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.